Groundbreaking findings from the landmark CLEAR (Clinical trial Comparing Lenvatinib with Ecerolimus or Pembrolizumab in ...
A guardian molecule ensures that liver cells do not lose their identity. The discovery is of great interest for cancer medicine because a change of identity of cells has come into focus as a ...
2d
News Medical on MSNNovel therapeutic approaches targeting the Wnt pathway in hepatocellular carcinomaHepatocellular carcinoma (HCC) is one of the deadliest cancers globally, with increasing incidence and mortality rates.
A new study in the Journal of Interferon & Cytokine Research (JICR) showed that a specific retinoic acid-inducible gene I ...
7mon
AZoLifeSciences on MSNStudy Identifies Microproteins as Key Source of Tumor-Specific Antigens in Liver CancerHowever, these cancers constitute over 90% of liver cancer cases ... of cancer-specific long noncoding RNAs. Studies on clear ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results